investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Metabolic pathways in leukemia
John D Schuetz
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
John D Schuetz
St. Jude Children's Research Hospital
Memphis, United States
Related projects
Yves Pommier
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
Leukaemia
Derek B. Sant'Angelo
Control of cytokine production by human NK cells
Leukaemia
Katerina V Gurova
Modulation of cancer specific transcriptional factors with small molecules
Leukaemia
Monica J Justice
The Pluripotency Regulator Prdm14 Initiates Cancer by Epigenetic Mechanisms
Leukaemia
Pathology
Hematology and hematologic malignancies
Zhe Li
IGF/IGF1R signaling in hematopoiesis and leukemogenesis
Leukaemia
Alan Rein
Retrovirus Assembly and Maturation – Rockville
Leukaemia
Pathology
Hematology and hematologic malignancies
Scott W Lowe
The impact of chromosome 17p lesions on leukemogeneis and therapy response
Leukaemia
Pathology
Hematology and hematologic malignancies
Clark W Distelhorst
Targeting PKM2-InsP3R interaction to treat AML
Leukaemia
Hematology and hematologic malignancies
David A Williams
Rac proteins in hematopoietic cell survival and function
Leukaemia
Hematology and hematologic malignancies